AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Danavish Trimetazidine 35mg Tablet MR

Prescription Icon
Prescription Required

Marketer

Danavish Healthcare

Salt Composition

Trimetazidine (35mg)

Overview Danavish Trimetazidine 35mg Tablet MR

Trimetazidine 35mg modified-release tablets (Danavish) are prescribed to manage angina, a type of chest pain linked to the heart. This medication helps prevent angina episodes but won't halt an attack already in progress. It's suitable for use independently or alongside other heart medications, as determined by your physician. Consistent daily intake, as directed, is crucial, regardless of food consumption. Dosage frequency may adjust based on treatment effectiveness. Continued use, even during symptom-free periods, maximizes protective benefits; discontinuation may trigger angina recurrence. A heart-healthy lifestyle, encompassing smoking cessation, reduced alcohol intake, a balanced diet, regular physical activity, and stress management, complements this treatment. Potential side effects include dizziness, headache, stomach discomfort, diarrhea, indigestion, nausea, vomiting, skin rash, itching, hives, and fatigue. Consult your doctor if any side effects persist or are troublesome. Prior medical conditions, such as liver or kidney disease, pregnancy, breastfeeding, or concurrent medications, require disclosure to your physician before starting this treatment.

Uses of Danavish Trimetazidine 35mg Tablet MR

Managing chest pain associated with angina pectoris

Major Benefits of Danavish Trimetazidine 35mg Tablet MR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Danavish Trimetazidine 35mg Modified-Release Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with a meal.

Common Side effects of Danavish Trimetazidine 35mg Tablet MR:

  • Dizziness
  • Headache
  • Nausea
  • Vomiting
  • Weakness
  • Rash
  • Abdominal pain
  • Indigestion
  • Itching
  • Diarrhea
  • Hives

How to use Danavish Trimetazidine 35mg Tablet MR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Danavish Trimetazidine 35mg Modified-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Danavish Trimetazidine 35mg Tablet MR works:

Trimetazidine 35mg Modified-Release tablets (Danavish brand) treat angina by altering the heart's energy source. This medication reduces the heart's oxygen demand through metabolic switching from fatty acids to glucose, improving cardiac efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Danavish Trimetazidine 35mg Modified-Release tablets and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of Danavish Trimetazidine 35mg Modified-Release tablets in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Danavish Trimetazidine 35mg Modified-Release tablets with breastfeeding are lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving may be unsafe while taking Danavish Trimetazidine 35mg MR tablets, as drowsiness, visual disturbances, and dizziness are potential side effects. Avoid operating a vehicle if you experience these effects.

KidneyKidneyCAUTION

Trimetazidine 35mg modified-release tablets (Danavish) require careful consideration in patients with impaired kidney function. Dosage modifications for Danavish Trimetazidine 35mg modified-release tablets may be necessary. Physician consultation is advised. Danavish Trimetazidine 35mg modified-release tablets are contraindicated in patients exhibiting severe kidney disease.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Danavish Trimetazidine 35mg Modified-Release tablets in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Danavish Trimetazidine 35mg Tablet MR :

Should you forget a dose of your Danavish Trimetazidine 35mg Modified-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Danavish Trimetazidine 35mg Tablet MR

LabelValue
Chemical Category Benzylamines
Developing Habits No.
Treatment Category Heart
Actions Fatty acid modulator and sodium channel inhibitor

FAQs on Danavish Trimetazidine 35mg Tablet MR

Danavish Trimetazidine 35mg MR tablets are not beta-blockers. This anti-anginal medication, used alongside other treatments, helps manage angina pectoris (chest pain from coronary artery disease) by shielding heart cells from oxygen deprivation during angina attacks.
Avoid Danavish Trimetazidine 35mg Tablet MR if you're allergic to it, have severe kidney disease, or have Parkinson's disease. Parkinson's disease is a brain disorder affecting movement, causing tremor, rigidity, slow movement, and gait instability.
For patients over 75, Danavish Trimetazidine 35mg MR tablets require careful use. Elderly patients typically receive lower doses to minimize adverse reactions, necessitating close monitoring.
Danavish Trimetazidine 35mg Tablet MR may rarely cause falls, potentially due to gait instability or postural hypotension. Elderly patients may be at increased risk and require closer monitoring and caution.
Danavish Trimetazidine 35mg MR tablets can cause dizziness and drowsiness. Avoid driving or operating machinery if affected.
Follow your doctor's instructions precisely when taking Danavish Trimetazidine 35mg Tablet MR. Swallow the tablet whole with plenty of liquid, such as water. This medication can be taken with or without food.
Danavish Trimetazidine 35mg MR tablets may cause dizziness, headache, abdominal pain, diarrhea, indigestion, rash, itching, and hives; some users experience nausea and weakness. Rare side effects include palpitations, orthostatic hypotension (potentially causing dizziness, lightheadedness, or fainting), falls, and flushing.
Danavish Trimetazidine 35...
52
MRP 60
13% off